This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the provision of TRIKAFTA 100-50-75 MG/150 MG pharmaceutical products, with an ultimate completion date of May 6, 2024.
The contract is not set aside and is issued under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that enables the DLA to place orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group supplies a variety of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense and Department of Veterans Affairs.
Generated 8/2/24, 9:10 AM